euro adhoc: MediGene AG / MEDIGENE IMPLEMENTS SPIN-OFF OF ITS CARDIOLOGICAL DRUG DISCOVERY PROGRAM: INDEPENDENT COMPANY LARNAX GMBH FOUNDED (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Martinsried/San Diego, March 31, 2003: Today the biopharmaceutical company MediGene AG (TecDax: MDG) and the seed capital investment company BioM AG jointly established LARNAX GmbH for the discovery ...